Materials Characterization

Expertise in analyzing material properties crucial for drug development, supporting all stages with specialized testing and cGMP-compliant facilities.

Resolian’s highly skilled team offers you experience on a wide range of samples including raw materials, active ingredients, excipients, stability samples, formulation intermediates and formulated products.

The Materials Characterization team supports routine measurements, advanced characterization, bespoke method development and validation, and troubleshooting at all stages of product development lifecycle, from pre-formulation to clinical phases to manufacturing.

Resolian’s cGMP laboratories in Kent, UK, are audited by the FDA and MHRA, and Resolian holds a controlled drugs license allowing for the handling of Schedule I to V controlled substances.

Resolian’s extensive experience can help you select the optimal solid form for your molecule, continuously supporting its critical characterization over a broad range of attributes and formulation stages.

Reach out to us directly to learn more about Resolian’s Materials Characterization services.

Benefits of Effective Materials Characterization

  • Identify compounds with desired properties early on, accelerate drug development process
  • Define target quality attributes
  • Optimize the formulation and manufacturing processes
  • Ensure drug safety and efficacy
  • Identify potential problems early on
  • Improve quality and consistency
  • Reduce risks
  • Improve profitability 

Testing Services

  • Inverse Gas Chromatography (iGC)
  • Dynamic Vapor Sorption (DVS)
  • Fourier Transform Infrared (FT-IR) Spectroscopy
  • Light Microscopy
  • Scanning Electron Microscopy (SEM)
  • Laser Diffraction
  • Dynamic Image Analysis (QICPIC)
  • Light Obscuration (HIAC)
  • Gas Adsorption Analysis
  • Gas Pycnometry
  • Bulk & Tap Density
  • Powder X-ray Diffraction (PXRD)
  • Differential Scanning Calorimetry (DSC)
  • Thermogravimetric Analysis (TGA)
  • Hot Stage Microscopy
  • Fourier Transform Infrared (FT-IR) Spectroscopy

Our
Resources

Our Resources

Biomarker Assay List

Bioanalytical LC-MS/MS Assay List 

Immunoassay Pharmacokinetics

Scroll to Top

Zhiyang Zhao, Ph.D.

Chief Scientific Officer

Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade. 

Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia. 

Patrick Bennett

Chief Executive Officer

Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now CEO at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD. 

Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.